381 related articles for article (PubMed ID: 32121271)
61. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review.
Shi L; Esfandiari L
Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687
[TBL] [Abstract][Full Text] [Related]
62. Liquid biopsy for precision diagnostics and therapeutics.
Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
[TBL] [Abstract][Full Text] [Related]
63. Liquid biopsy for brain tumors.
Shankar GM; Balaj L; Stott SL; Nahed B; Carter BS
Expert Rev Mol Diagn; 2017 Oct; 17(10):943-947. PubMed ID: 28875730
[TBL] [Abstract][Full Text] [Related]
64. One sample fits all: a microfluidic-assisted methodology for label-free isolation of CTCs with downstream methylation analysis of cfDNA in lung cancer.
Carvalho Â; Guimarães-Teixeira C; Constâncio V; Fernandes M; Macedo-Silva C; Henrique R; Monteiro FJ; Jerónimo C
Biomater Sci; 2022 Jun; 10(12):3296-3308. PubMed ID: 35583893
[TBL] [Abstract][Full Text] [Related]
65. Microfluidic biosensing of circulating tumor cells (CTCs): Recent progress and challenges in efficient diagnosis of cancer.
Farshchi F; Hasanzadeh M
Biomed Pharmacother; 2021 Feb; 134():111153. PubMed ID: 33360045
[TBL] [Abstract][Full Text] [Related]
66. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
[TBL] [Abstract][Full Text] [Related]
67. [Breakthrough Technologies: Liquid Biopsy -Chairmen's Introductory Remarks.].
Nakatani K; Furuta K
Rinsho Byori; 2016 May; 64(4):392-393. PubMed ID: 29182804
[TBL] [Abstract][Full Text] [Related]
68. Urine biopsy technologies: Cancer and beyond.
Chen CK; Liao J; Li MS; Khoo BL
Theranostics; 2020; 10(17):7872-7888. PubMed ID: 32685026
[TBL] [Abstract][Full Text] [Related]
69. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives.
Galoș D; Gorzo A; Balacescu O; Sur D
Cells; 2022 Nov; 11(21):. PubMed ID: 36359889
[TBL] [Abstract][Full Text] [Related]
70. Microfluidic Acoustic Method for High Yield Extraction of Cell-Free DNA in Low-Volume Plasma Samples.
Conde AJ; Keraite I; Leslie NR; Kersaudy-Kerhoas M
Methods Mol Biol; 2023; 2679():163-180. PubMed ID: 37300615
[TBL] [Abstract][Full Text] [Related]
71. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
Kong W; Chen T; Li Y
Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
[TBL] [Abstract][Full Text] [Related]
72. Simultaneous BRAF
Wuethrich A; Dey S; Koo KM; Sina AAI; Trau M
Methods Mol Biol; 2021; 2265():265-276. PubMed ID: 33704721
[TBL] [Abstract][Full Text] [Related]
73. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
74. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
75. High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics.
Zhu Z; Zhang Y; Zhang W; Tang D; Zhang S; Wang L; Zou X; Ni Z; Zhang S; Lv Y; Xiang N
Biosens Bioelectron; 2024 Sep; 259():116411. PubMed ID: 38781696
[TBL] [Abstract][Full Text] [Related]
76. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.
Li X; Seebacher NA; Hornicek FJ; Xiao T; Duan Z
Cancer Lett; 2018 Dec; 439():66-77. PubMed ID: 30223067
[TBL] [Abstract][Full Text] [Related]
77. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
[TBL] [Abstract][Full Text] [Related]
78. Liquid biopsy: A new avenue in pathology.
Ghosh RK; Pandey T; Dey P
Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
[TBL] [Abstract][Full Text] [Related]
79. Toward Microfluidic Label-Free Isolation and Enumeration of Circulating Tumor Cells from Blood Samples.
Raillon C; Che J; Thill S; Duchamp M; Desbiolles BXE; Millet A; Sollier E; Renaud P
Cytometry A; 2019 Oct; 95(10):1085-1095. PubMed ID: 31364817
[TBL] [Abstract][Full Text] [Related]
80. Liquid biopsy in colorectal cancer.
Najafi S; Majidpoor J; Mortezaee K
Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
